- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05262946
Sensorimotor Training for Adults With Diabetic Peripheral Neuropathy
November 3, 2022 updated by: Universidad Complutense de Madrid
Somatosensory Restoration and Postural Control Improvement in People With Diabetic Peripheral Neuropathy Applying Sensorimotor Training: a Multicentric Randomized Controlled Trial
Adults with diabetic peripheral neuropathy tend to fall more frequently than healthy population as a consequence of multiple sensorimotor and cognitive damages.
In this protocol study, a randomized controlled trial is proposed using a sensorimotor intervention based on Feldenkrais method to improve somatosensory aspects and, therefore, postural control of participants.
Study Overview
Status
Completed
Detailed Description
Among all the systems suffering damage due to hyperglucemia toxicity in diabetes, somatosensory system, composed by proprioception and skin sensory receptors has a key role since it is in charge of the faster body reaction when a postural control response is needed.
Despite of it, few studies have focused on this issue.
This randomized controlled trial proposed a safe and easy training adapted to adults and old people with diabetic peripheral neuropathy.
Pressure, touch, proprioception and graphesthesia sensibility were measured, as well as functionality in daily basis, quality of life and fear of falling.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: having peripheral neuropathy and history of falls or risk factors for it. Current ulcer -
Exclusion Criteria: amputation and cognitive or mental issues
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: control
control arm: usual care and foot care education.
|
Recommendations for preventing foot ulcers
drugs and diet usual care
|
Experimental: experimental
experimental arm: sensorimotor training, foot care education and usual care
|
Recommendations for preventing foot ulcers
drugs and diet usual care
8 weeks of balance and sensorimotor training twice a week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cumulative Somatosensory Impairment Index
Time Frame: 2 years
|
It measures proprioception, pressure and vibration sensitivity and graphesthesia to sum up somatosensory function in lower legs.
Iti is ranging from 0 to 8 being 8 the worst result
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Up and Go test
Time Frame: 2 years
|
postural control test
|
2 years
|
Four Square Step test
Time Frame: 2 years
|
ability walking in different directions
|
2 years
|
Tinetti- Performance-Oriented Mobility Assessment (POMA-T)
Time Frame: 2 years
|
static and dynamic postural control
|
2 years
|
Falls Efficacy Scale
Time Frame: 2 years
|
It measures the fear of falling, ranging from 0 to 64, being higher scores worst outcome results
|
2 years
|
SF-36 Health Survey questionnaire , 1.4 version.
Time Frame: 2 years
|
Quality of life health-related questionnaire
|
2 years
|
Validated Spanish version of Short-Form Late-Life Function and Disability Instrument
Time Frame: 2 years
|
It measures functional disabilities and frequency of daily life activities, ranging from 31 to 155 and being higher scores better outcome results.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: MARIA TERESA ANGULO CARRERA, DR, Universidad Complutense Madrid
- Study Director: NOEMI GONZALEZ PEREZ DE VILLAR, DR, Hospital Universitario de La Paz
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
December 22, 2019
Study Completion (Actual)
January 30, 2022
Study Registration Dates
First Submitted
January 31, 2022
First Submitted That Met QC Criteria
February 21, 2022
First Posted (Actual)
March 2, 2022
Study Record Updates
Last Update Posted (Actual)
November 4, 2022
Last Update Submitted That Met QC Criteria
November 3, 2022
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DiabetesBalanceOne
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Neuropathy
-
Arash Asher, MDVoxxLifeRecruitingNeuropathy | Chemotherapy-induced Peripheral Neuropathy | Neuropathy;PeripheralUnited States
-
Beth Israel Deaconess Medical CenterPhoenix Neurological Associates, LTDCompletedSmall Fiber Neuropathy | Idiopathic Peripheral NeuropathyUnited States
-
M.D. Anderson Cancer CenterFoundation for Anesthesia Education and ResearchRecruitingNeuropathy;PeripheralUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Institut Cancerologie de l'OuestGrünenthal GmbHNot yet recruitingChemotherapy-induced Peripheral Neuropathy
-
Odense University HospitalAarhus University Hospital; University of Southern Denmark; Sygehus LillebaeltRecruitingChemotherapy-induced Peripheral NeuropathyDenmark
-
WinSanTor, IncRecruitingChemotherapy-induced Peripheral NeuropathyUnited States
-
Veloxis PharmaceuticalsRecruitingChemotherapy-induced Peripheral NeuropathyUnited States, Japan
-
National University Hospital, SingaporePaxman Coolers Ltd.; The N.1 Institute for Health, National University of SingaporeRecruitingChemotherapy-induced Peripheral NeuropathySingapore
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingChemotherapy-Induced Peripheral NeuropathyUnited States
Clinical Trials on foot care education
-
Temple UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus | Diabetic Neuropathies | Foot ComplicationsUnited States
-
Universidade do AlgarveUniversity of Huelva; OKM Química Ortopédica S.L.; Lola - J. Andrade Ferreira... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Diabetic Peripheral NeuropathyPortugal
-
Okayama UniversityCompletedDiabetic Peripheral NeuropathyJapan
-
Sanidad de Castilla y LeónCompletedImprovement of Diabetic Foot Care in Salamanca Through the Implementation of Standardized Protocols.Diabetes | Diabetic Foot | Primary Health CareSpain
-
Fatma ÖzkalNecmettin Erbakan UniversityCompleted
-
Istanbul Medeniyet UniversityCompletedDiabetic Foot, Mobile Application, Patient Education
-
Case Western Reserve UniversityKent State UniversityCompletedDiabetes | Visual ImpairmentUnited States
-
Fisseha Z AmdieRecruitingDiabetes Foot CareEthiopia
-
Ondokuz Mayıs UniversityActive, not recruitingDiabetic Foot UlcerTurkey
-
T.C. ORDU ÜNİVERSİTESİTC Erciyes UniversityCompleted